Global Obliterative Bronchiolitis Market, By Drug Class (Immunosuppressive Agents, Azithromycin, Inhaled Fluticasone, Oral Montelukast, Corticosteroids and Cytotoxic Agents, Others), Symptoms (Breath, Dry Cough, Respiratory Illness, Others), Diagnosis (Chest CT scan, Pulmonary Infection Test, Chest X Ray, Pulmonary Function Test), Treatment (Lung Transplant, Drugs, Others), End User (Hospitals, Clinics, Diagnostic Centers, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028